Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
Submitted by
admin
on October 16, 2012 - 11:29am
Source:
PharmPro
News Tags:
FTC
Watson Pharmaceuticals
M&A
Actavis
Headline:
FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
Do Not Allow Advertisers to Use My Personal information
